000			03961nam a2200457 i 4500
999			_c122013 _d122013 _x1
001			122013
003			ES-MaUEC
005			20230102114158.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			200707s2020 gw a fo |||| 0|eng d
020			_a9783030455620
024	7		_a10.1007/978-3-030-45562-0 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC685.H8 _b2020 EB
245	0	0	_aSecondary Hypertension _cedited by Alberto Morganti, Enrico Agabiti Rosei, Franco Mantero
250			_aFirst edition
264		1	_aCham, Switzerland _bSpringer International Publishing _c2020
300			_a1 recurso en línea (X, 209 páginas) _b22 ilustraciones, 9 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aUpdates in Hypertension and Cardiovascular Protection _x2366-4606
490	0		_aMedicine (SpringerNature-11650)
490	0		_aMedicine (R0) (SpringerNature-43714)
505	0		_a1. Renal parenchimal disease -- 2. Atherosclerotic renovascular disease -- 3. Fibromuscular Dysplasia -- 4. Primary aldosteronism -- 5. Familial aldosteronism -- 6. Monogenic forms of hypertension. - 7. Pheochromocytoma - Paraganglioma -- 8. Cushing disease -- 9. Vascular disease -- 10. OSAS -- 11. Drug induced hypertension -- 12. Acromegaly -- 13. Organ damage in secondary hypertension. - 14. Hemodynamics and CV risk in secondary hypertension.
520			_aThis book offers an overview of the latest advances in the epidemiological, pathophysiological, diagnostic and therapeutic aspects of secondary hypertension, provided by a group of the most highly respected European experts in this field. It is common belief that secondary forms of hypertension are rare, although in 95% of patients the cause of high blood pressure is unknown - euphemistically referred to as "essential". There is increasing evidence from epidemiological studies that the prevalence of secondary hypertension is much higher than previously thought, accounting for 20%-25% of all hypertensive patients. There are additional, very good reasons for identifying those patients with secondary hypertension: firstly, they are exposed to a greater risk of suffering major cardiovascular events than patients with essential hypertension who have the same blood pressure level, and for this reason require particular care. Secondly, these patients can be relieved of a lifetime of pharmacological therapy or, at least, have a chance to be treated with more specific and effective medications. A high degree of clinical skill is required to recognize the often vague and subtle symptoms and signs that characterize patients with secondary hypertension, and clinicians need to fully comprehend the mechanisms responsible for the development and maintenance of high blood pressure. Shedding new light on a complex area of cardiovascular medicine, the book enables readers to better treat affected patients.
988			_aSpringer_Medicine_2020
650		7	_2embne _aHipertensión _9140794
650		7	_2embne _aCorazón _xEnfermedades _9169667
700	1		_aMorganti, Alberto _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aAgabiti Rosei, Enrico _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _1http://viaf.org/viaf/315225048 _995170
700	1		_aMantero, Franco _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _1http://viaf.org/viaf/50611673
776	0	8	_iPrinted edition: _z9783030455613
776	0	8	_iPrinted edition: _z9783030455637
776	0	8	_iPrinted edition: _z9783030455644
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-45562-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b09/2020 _dz _eb _zSI